| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/24/2014 | EP2781215A1 Topical patch preparation for treatment of toxicity of mosquitoes |
| 09/24/2014 | EP2780373A1 Anti il-36r antibodies |
| 09/23/2014 | US8841261 Functional powdery product |
| 09/23/2014 | US8841254 Method for treatment of anxiety |
| 09/23/2014 | US8841250 Method for promoting muscle repair comprising administering G-CSF at the site of injury |
| 09/23/2014 | CA2602968C Crystals of morphinan derivative and process for producing the same |
| 09/23/2014 | CA2473039C Novel anti-igf-ir antibodies and uses thereof |
| 09/18/2014 | WO2014145784A1 Methods of delivering nanoshells into sebaceous glands |
| 09/18/2014 | WO2014145295A1 Topical compositions for reducing aging effects |
| 09/18/2014 | WO2014145067A1 Topical compositions of flunisolide and methods of treatment |
| 09/18/2014 | WO2014145042A1 Treatment of autoimmune diseases |
| 09/18/2014 | WO2014145037A1 Methods and compositions for enhancing oxygen levels in tissues |
| 09/18/2014 | WO2014144772A1 Methods of promoting wound healing using crm1 inhibitors |
| 09/18/2014 | WO2014144075A1 Anticholinergic glycopyrrolate esters for the treatment of hyperhidrosis |
| 09/18/2014 | WO2014143146A1 Methods of administering monomethyl fumarate |
| 09/18/2014 | WO2014142675A1 Nanofibre and bioactive compositions and related methods |
| 09/18/2014 | WO2014142356A1 Therapeutic agent for scleroderma |
| 09/18/2014 | WO2014142255A1 Heterocyclic compound |
| 09/18/2014 | WO2014142116A1 Ceramide-like function imparting agent |
| 09/18/2014 | WO2014140695A1 Solid oral formulation of a pyrrolidine substituted flavone compound |
| 09/18/2014 | WO2014140597A1 2-((4-amino-3-(3-fluoro-5-hydroxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-1 -yl)methyl)-3-(2-(trifluoromet hyl)benzyl)quinazolin-4(3h)-one derivatives and their use as phosphoinositide 3-kinase inhibitors |
| 09/18/2014 | WO2014140524A1 Pharmaceutical composition for the treatment of fungal infections |
| 09/18/2014 | WO2014140507A1 Pharmaceutical composition for the treatment of fungal infections |
| 09/18/2014 | WO2014140313A1 Macrocyclic salt-inducible kinase inhibitors |
| 09/18/2014 | WO2014140299A1 Macrocyclic rip2 kinase inhibitors |
| 09/18/2014 | WO2014140075A1 Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c |
| 09/18/2014 | WO2014139443A1 Low immunogenicity human cell and preparation method therefor |
| 09/18/2014 | WO2014138930A1 Biophotonic materials and uses thereof |
| 09/18/2014 | US20140275545 8-carboxamido-2,6-methano-3-benzazocines |
| 09/18/2014 | US20140275479 Specific binding agents of human angiopoeitin-2 |
| 09/18/2014 | US20140271921 Pharmaceutical composition |
| 09/18/2014 | US20140271637 Methods of administering anti-tnfalpha antibodies |
| 09/17/2014 | EP2778223A1 Vascular progenitor cell sheet derived from induced pluripotent stem cells, and production method therefor |
| 09/17/2014 | EP2777706A1 Methods for increasing the production or activity of catalase |
| 09/17/2014 | EP2777689A1 New pharmaceutical composition for the treatment of fungal infections |
| 09/17/2014 | EP2776393A1 Nampt inhibitors |
| 09/17/2014 | EP2776052A1 Methods and compositions for wound treatment |
| 09/17/2014 | EP2776045A1 A hydrocolloid composition and an article containing the same |
| 09/17/2014 | EP2776034A1 Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions |
| 09/17/2014 | EP2776020A1 Methods for the treatment of skin neoplasms |
| 09/17/2014 | EP2775996A2 Use of propanol and propenol derivatives as antioxidants |
| 09/17/2014 | EP2775874A1 Pharmaceutical composition for the prevention and the treatment of degenerative skin disorders especially caused by ionizing radiations |
| 09/16/2014 | US8835435 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 09/16/2014 | US8835430 2,4-pyrimidinediamine compounds and their uses |
| 09/16/2014 | US8834943 Compositions containing amines and use thereof |
| 09/16/2014 | US8834897 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 09/16/2014 | CA2778317C Topical composition comprising n-acetylaldosamines or n-acetylamino acids |
| 09/16/2014 | CA2633040C Composition of inverse emulsion type comprising ivermectin, and uses thereof in cosmetics and dermatology |
| 09/16/2014 | CA2611831C A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
| 09/12/2014 | WO2014138710A1 Stem cell compositions and methods for wound healing |
| 09/12/2014 | WO2014138046A1 Use of agonists of formyl peptide receptor 2 for treating dermatological diseases |
| 09/12/2014 | WO2014137961A1 Anti-tnf-anti-il-17 bispecific antibodies |
| 09/12/2014 | WO2014135529A1 Mixture of fatty acids for use in the treatment of inflammatory pathologies |
| 09/12/2014 | WO2014134846A1 Traditional chinese medicine composition for treating dairy cow laminitis and preparation method for same |
| 09/12/2014 | WO2014134834A1 Composition and food comprising same and preparation method of food |
| 09/12/2014 | WO2014134731A1 Antimicrobial-antibiofilm compositions and methods of use thereof |
| 09/12/2014 | WO2014134701A1 Antimicrobial-antibiofilm compositions and methods of use thereof |
| 09/12/2014 | WO2014107745A9 Metal sensitive mutants of matrix metalloproteases and uses thereof |
| 09/11/2014 | US20140256652 Polypeptides Involved In Immune Response |
| 09/11/2014 | US20140255493 Extrudate and methods of using said extrudate |
| 09/11/2014 | US20140255396 Multiple-variable dose regimen for treating tnfalpha-related disorders |
| 09/11/2014 | DE102013204081A1 Wirkstoffkombinationen aus Alkylamidothiazolen und einen oder mehreren kosmetisch oder dermatologisch unbedenklichen Konservierungsmitteln Active compound combinations of Alkylamidothiazolen and one or more cosmetically or dermatologically acceptable preservatives |
| 09/11/2014 | DE102013204070A1 Verwendung kosmetisch oder dermatologisch unbedenklicher substituierter Michael-Akzeptoren zur Verhinderung, Verminderung oder Prophylaxe der Tyrosinaseaktivität der menschlichen Haut und/oder deren Aufhellung Use of cosmetically or dermatologically acceptable substituted Michael acceptors for the prevention, reduction or prevention of the tyrosinase activity of the human skin and / or brightening |
| 09/10/2014 | EP2774618A2 Pharmaceutical composition based on epigallocatechin gallate-containing nano-micelles and use thereof to treat atopic dermatitis, crohn's disease, adenomyosis and hyperplastic prostate disorders |
| 09/10/2014 | EP2773645A1 Imidazopyridazine compounds |
| 09/10/2014 | EP2773367A1 S100 family proteins and their uses |
| 09/10/2014 | EP2773343A2 Cosmetic use of n-heteroarylbisamide analogs and related compounds |
| 09/10/2014 | EP2773324A2 Stable dermatological aerosol foams utilizing reactive propellants |
| 09/09/2014 | US8828973 Compounds as receptor modulators with therapeutic utility |
| 09/09/2014 | US8828959 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells |
| 09/09/2014 | US8828947 Polypeptide formulation |
| 09/09/2014 | US8828385 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 09/09/2014 | CA2782927C Derivatives of novel peroxides, method of preparation thereof and use thereof in human medicine as well as in cosmetics for the treatment or prevention of acne |
| 09/09/2014 | CA2774040C 2, 3-dihydro-1h-inden-2-yl urea derivatives and medical uses thereof |
| 09/09/2014 | CA2657718C Use of polyethylene glycol in inflammation related topical disorders or diseases and wound healing |
| 09/09/2014 | CA2602522C Method of treating skin ulcers using oxidative reductive potential water solution |
| 09/09/2014 | CA2596599C Epidermis equivalent capable of pigmenting obtained from matrix cells, preparation process and use |
| 09/04/2014 | WO2014134620A1 Acne solution |
| 09/04/2014 | WO2014134427A1 Controlling the bioavailability of active ingredients in topical formulations |
| 09/04/2014 | WO2014134404A1 Glycyrrhetinimidyl hydroxyproline alkyl esters and protected derivatives thereof |
| 09/04/2014 | WO2014132213A1 Compounds, processes for extracting them from kelp, compositions containing said compounds and use of said compositions |
| 09/04/2014 | WO2014132060A1 Skincare compositions |
| 09/04/2014 | US20140249232 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
| 09/04/2014 | US20140249198 Melatonin and its use in preventing postoperative complications |
| 09/04/2014 | US20140248700 Method of Differentiation of Morula or Inner Cell Mass Cells and Method of Making Lineage-Defective Embryonic Stem Cells |
| 09/04/2014 | US20140248277 Multiple-variable dose regimen for treating tnfalpha-related disorders |
| 09/04/2014 | US20140248276 Multiple-variable dose regimen for treating tnfalpha-related disorders |
| 09/04/2014 | US20140248275 Multiple-variable dose regimen for treating tnfalpha-related disorders |
| 09/04/2014 | DE10297513C5 In vitro Herstellung von dendritischen Zellen aus CD14+ Monocyten In vitro production of dendritic cells from CD14 + monocytes |
| 09/03/2014 | EP2772498A1 Polypeptides inhibiting neovascularization and uses thereof |
| 09/03/2014 | EP2772482A1 Azole derivative |
| 09/03/2014 | EP2772255A1 Composition comprising syringaresinol for improving the skin |
| 09/03/2014 | EP2771334A1 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies |
| 09/03/2014 | EP2771329A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases |
| 09/03/2014 | EP2771318A1 Novel esters of n-acyl derivatives of amino acids and diols, method for preparing same, and use thereof in cosmetics and as a drug |
| 09/02/2014 | US8822685 2,4-pyrimidinediamine compounds and their uses |
| 09/02/2014 | US8822481 Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile |
| 09/02/2014 | US8822477 Use of osmolytes obtained from extremophilic bacteria for producing medicine for the external treatment of neurodermatitis |
| 09/02/2014 | US8821934 Pullulan-containing powder, process for producing the same and use thereof |
| 09/02/2014 | US8821933 Polymers and hydrogels |